Merck (MRK) Non-Current Debt (2009 - 2026)

Merck (MRK) has 18 years of Non-Current Debt data on file, last reported at $46.7 billion in Q1 2026.

• Quarterly Non-Current Debt rose 39.39% year-over-year to $46.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $46.7 billion (up 39.39% YoY) and the FY2025 annual result came in at $46.8 billion, up 35.66% from the prior year.
• Non-Current Debt held at $46.7 billion in Q1 2026 per MRK's latest filing, from $46.8 billion in the prior quarter.
• Across five years, Non-Current Debt topped out at $46.8 billion in Q4 2025 and bottomed at $28.1 billion in Q1 2023.
• The 5-year median for Non-Current Debt is $34.0 billion (2025), against an average of $34.3 billion.
• The widest annual swing landed in 2023, when Non-Current Debt dropped 8.21%; it then surged 39.39% in 2026.
• Tracing MRK's Non-Current Debt over 5 years: stood at $28.7 billion in 2022, then rose by 17.18% to $33.7 billion in 2023, then advanced by 2.31% to $34.5 billion in 2024, then surged by 35.66% to $46.8 billion in 2025, then decreased by 0.16% to $46.7 billion in 2026.
• Per Business Quant, the three latest MRK Non-Current Debt figures stand at $46.7 billion (Q1 2026), $46.8 billion (Q4 2025), and $40.0 billion (Q3 2025).

Peer Comparison